Pancreatic delta cell neuroendocrine tumor

disease
On this page

Also known as pancreatic Delta cell neoplasmpancreatic Delta cell NETpancreatic Delta cell neuroendocrine tumourpancreatic Delta cell tumorpancreatic Delta cell tumour

Summary

Pancreatic delta cell neuroendocrine tumor (MONDO:0002994) is a cancer. A subtype of epithelial neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepancreatic delta cell neuroendocrine tumor
Mondo IDMONDO:0002994
DOIDDOID:4433
NCITC28396
UMLSC1335301
MedGen233303
GARD0023315
Is cancer (heuristic)yes

Also known as: pancreatic Delta cell neoplasm · pancreatic delta cell neoplasm · pancreatic Delta cell NET · pancreatic Delta cell neuroendocrine tumor · pancreatic Delta cell neuroendocrine tumour · pancreatic Delta cell tumor · pancreatic Delta cell tumour

Disease family

An umbrella term covering 2 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasm › epithelial neoplasm › pancreatic delta cell neuroendocrine tumor

Related subtypes (23): ovarian epithelial tumor, myoepithelial tumor, endometrioid tumor, squamous cell neoplasm, thyroid hyalinizing trabecular adenoma, Wolffian adnexal tumor, adenoma, carcinoma, cystic, mucinous, and serous neoplasm, thymic epithelial neoplasm, epithelial tumor of anal canal, growth hormone-producing pituitary gland neoplasm, basal cell neoplasm, sympathetic paraganglioma, papillary epithelial neoplasm, epithelial skin neoplasm, glandular cell neoplasm, intraepithelial neoplasia, epithelial neoplasm of rectum, epithelial tumor of colon, mesonephric neoplasm, benign epithelial neoplasm, transitional cell neoplasm

Subtypes (2): pancreatic somatostatinoma, pancreatic non-functioning delta cell tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.